DT&CRO CO., Ltd. Logo

DT&CRO CO., Ltd.

A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.

383930 | KO

Overview

Corporate Details

ISIN(s):
KR7383930005
LEI:
Country:
South Korea
Address:
경기도 용인시 처인구 백령로20번길 28 나동 2, 3, 4층(유방동), 용인시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DT&CRO CO., Ltd. is a full-service Contract Research Organization (CRO) that provides comprehensive development support for the pharmaceutical, biotechnology, medical device, and chemical industries. The company offers a complete suite of services covering the entire product lifecycle, from non-clinical GLP toxicity studies, pharmacokinetic (PK) tests, and efficacy evaluations to clinical trials. A key specialization is its "Full Package Service" for U.S. FDA approval, offering end-to-end consulting and application support for Investigational New Drug (IND) and New Drug Application (NDA) submissions. DT&CRO is also noted for being the first Korean organization to develop an in-house CDISC SEND program for standardized data submission and offers MoPS, a proprietary IT platform for real-time project management and client communication.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-09 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-09-08 00:00
Regulatory News Service
단일판매ㆍ공급계약체결(자율공시)
Korean 9.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-08-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.7 KB
2025-08-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 88.3 KB
2025-06-16 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.8 KB
2025-06-11 00:00
Related Party Transaction
임원ㆍ주요주주특정증권등거래계획철회보고서
Korean 17.4 KB
2025-06-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-06-05 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.3 KB
2025-05-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.6 KB
2025-05-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 85.4 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.1 MB
2025-04-16 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 42.0 KB
2025-04-15 00:00
Director's Dealing
임원ㆍ주요주주특정증권등거래계획보고서
Korean 41.9 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.9 KB

Automate Your Workflow. Get a real-time feed of all DT&CRO CO., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DT&CRO CO., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DT&CRO CO., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Xenetic Biosciences, Inc. Logo
Advancing DNase & CAR T immune-oncology platforms to treat hard-to-treat cancers.
United States of America
XBIO
Xilio Therapeutics, Inc. Logo
Engineering tumor-activated biologics for cancer to maximize efficacy and minimize toxicity.
United States of America
XLO
XLMEDIA PLC Logo
A former performance marketing company for the sports and gaming industries.
Jersey
XLM
XORTX Therapeutics Inc. Logo
Developing late-stage, uric acid-lowering therapies for gout and progressive kidney disease.
United States of America
XRTX
Xplus Inc. Logo
IT consultancy guiding digital transformation via enterprise architecture & program management.
South Korea
373200
XTL Biopharmaceuticals Ltd. Logo
Acquires and develops late-stage drugs for unmet medical needs, focusing on autoimmune diseases.
Israel
XTLB
YAMADA Consulting Group  CO.,LTD. Logo
Japanese consulting firm offering global M&A, strategy, and financial advisory services.
Japan
4792
Y-Biologics, Inc Logo
Develops novel antibody cancer therapies using proprietary T-cell engager & antibody library tech.
South Korea
338840
Yellow Balloon Tour Co., Ltd. Logo
Offers domestic & international travel packages, flights, and tours for individuals and groups.
South Korea
104620
Yoshimura Food Holdings K.K. Logo
Acquires and revitalizes Japanese food SMEs via a support platform for global expansion.
Japan
2884

Talk to a Data Expert

Have a question? We'll get back to you promptly.